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Malignant mesothelioma is a poor prognosis cancer in urgent need of alternative therapies. Oleuropein, the major phenolic of
olive tree (Olea europaea L.), is believed to have therapeutic potentials for various diseases, including tumors. We obtained an
oleuropein-enriched fraction, consisting of 60%w/w oleuropein, from olive leaves, and assessed its effects on intracellular Ca2+ and
cell viability in mesothelioma cells. Effects of the oleuropein-enriched fraction on Ca2+ dynamics and cell viability were studied in
the RENmesothelioma cell line, using fura-2microspectrofluorimetry andMTT assay, respectively. Fura-2-loaded cells, transiently
exposed to the oleuropein-enriched fraction, showed dose-dependent transient elevations of cytosolic Ca2+ concentration ([Ca2+]i).
Application of standard oleuropein and hydroxytyrosol, and of the inhibitor of low-voltage T-type Ca2+ channels NNC-55-0396,
suggested that the effect is mainly due to oleuropein acting through its hydroxytyrosol moiety on T-type Ca2+ channels. The
oleuropein-enriched fraction and standard oleuropein displayed a significant antiproliferative effect, as measured on REN cells
by MTT cell viability assay, with IC
50
of 22 𝜇g/mL oleuropein. Data suggest that our oleuropein-enriched fraction from olive leaf
extract could have pharmacological application in malignant mesothelioma anticancer therapy, possibly by targeting T-type Ca2+
channels and thereby dysregulating intracellular Ca2+ dynamics.
1. Introduction
Malignant mesothelioma is a poor prognosis cancer with
worldwide increasing insurgence, arising from the pleura and
other mesothelial tissue and showing close association with
asbestos exposure. An effective therapeutic approach for the
disease is currently lacking, while alternative treatments are
urgently needed [1]. Among alternative remedies for cancer
treatment, there is a growing interest in the anticancer action
of natural substances, some of which are present in large
amounts in byproducts from agrofood chains.
Olive (Olea europaea L.) is a main temperate fruit crop,
mostly destined to oil production [2].Olive oil is reputed to be
an important health promoting factor in the Mediterranean
diet, especially because of its alleged prevention of cardio-
vascular problems, metabolic syndrome, cancer, alleviation
of inflammatory and autoimmune conditions, and wound
healing [3]. However, olive tree leaves have a several-century-
long tradition in the folk medicines of the Mediterranean
basin and are currently contemplated in the Pharmacopoeia
Ph. Eur. 5 [4].
Leaves and other materials from olive tree pruning
accumulate in yearly amounts as high as about 25 kg per tree
[5]. This material is generally disposed by olive tree growers,
representing an overhead cost of olive and oil production,
while the possibility of using it as biomass for thermal energy
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is under study [6]. Olive leaves are used in the form of herbal
extracts, tea, and powder for nutritional supplement and
cosmetics [4], but these products represent aminimal portion
with respect to the huge amount of disposed materials.
The major leaf secondary metabolite is the secoiridoid
oleuropein, a glycosylated ester of elenolic acid with hydrox-
ytyrosol (2-(3,4-dihydroxyphenyl)ethanol). Oleuropein leaf
content has been reported to vary about tenfold among differ-
ent olive varieties, rating on average between 10 and 100mg/g
of dry matter [7, 8]. Many other biologically active phenolics
are present in olive leaves, including hydroxytyrosol itself [9].
Oleuropein is deemed to have great potential as an antiox-
idant and food additive, but also as a possible therapeutic
tool. A wide range of studies on oleuropein have been carried
out using in vitro assays, animal models of disease, or human
volunteers, in order to explore possible beneficial effects for
human health [10]. The reported findings mainly include
antioxidant and anti-inflammatory effects, hepatoprotection,
neuroprotection, hypoglycemic and hypolipidemic activities,
and cardiovascular protection [11, 12]. Antiproliferative activ-
ities on cancer cell lines, antitumor effects in animals, and
antimicrobial and antiviral effects have also been shown [13].
Hydroxytyrosol in olive leaves, fruits, and extracts is
believed to derive from oleuropein hydrolysis, both by spe-
cific enzymes and as an extraction artifact [9]. In vitro and
in vivo studies suggest that this compound shares remarkable
antioxidant and anti-inflammatory power with oleuropein,
allegedly related to antiatherogenic, antithrombotic, cardio-
protective, and anticancer effects [14, 15].
The value of olive leaf extract for possible use in health
products and medical food has been previously assessed in
terms of antioxidant and antimicrobial power [16]. However,
the profitable reutilization of agrofood chain byproducts
needs to overcome several problems, including the costs
of transport and processing and the seasonal availability of
these materials. In this study, we have developed a rapid
method for obtaining olive leaf extract enriched in oleu-
ropein, involving raw extraction, extract partitioning, and
chromatographic separation. The material has been tested in
pharmacologically relevant, intracellular Ca2+ mobilization
assay and antiproliferative assay on mesothelioma cells. In
these experiments, standard oleuropein has been used as
control, while hydroxytyrosol has been also used in Ca2+
assays to provide insight into the Ca2+ mobilizing properties
of the oleuropein molecule.
2. Materials and Methods
2.1. Plant Material. Branch specimens of Olea europaea L.
cultivar “Taggiasca” [17] were obtained from olive groves
located at Imperia, Italy, owned by the Pietro Isnardi S.r.l.
food company. The material was taxonomically identified
by one of us (LC), and a voucher specimen was deposited
at DISTAV, University of Genova (cat.: GE-Olea europaea
cultivar “Taggiasca”). Leaves were separated from twigs, air-
dried for one week, minced to <1mm using a grinder, and
then subjected to extraction procedure.
2.2. Reagents and Solutions. HPLC grade methanol Chro-
masolv (>99.9%) and glacial acetic acid were purchased
from Sigma-Aldrich (Milwaukee, USA). Ammonium acetate
(99%) was acquired from Fluka (Buchs, Switzerland). Ultra-
pure water was produced by a Millipore Milli-Q system
(Milford, USA). Analytical grade chemicals were purchased
from Sigma-Aldrich, unless otherwise specified.
For LC/MS analysis, standard stock solutions of oleuro-
pein and hydroxytyrosol (each at concentration of
100.0mg L−1) were prepared in methanol and diluted as
required with a buffer solution of ammonium acetate
10.0mM brought to pH 4.0 for acetic acid. For in vitro
bioassays, stock solutions of oleuropein and hydroxytyrosol
(each at 100mM) were prepared in DMSO and diluted
as indicated with cell medium or loading buffer for Ca2+
measurements. Stock solutions were preserved at −20∘C in
dark conditions and were stable for three months.
2.3. Olive Leaf Extraction Procedure. The minced leaves
were extracted with a mixture of 2-propanol : water of 9 : 1.
Aliquots of 10 g of leaves were extracted twice with 200mL
of solvent each time. The extraction was carried out at RT
for about 1.5 h. The resulting solutions were mixed and the
solvent was eliminated under vacuum, yielding an amount of
2.35 g of driedmaterial.This raw extract was then partitioned
between a mixture of methanol : water of 3 : 1 and a mixture
of toluene : petroleum ether of 2 : 1 (100mL each phase). The
hydrocarbon phase became deep green, indicating that it
contained all the chlorophyll of the raw extract. The aqueous
methanol phase was dried under vacuum, yielding 1.8 g of
subextract. This material was then again partitioned between
water and 2-butanone (100mL each phase), to remove sugars
and other water-soluble compounds. The organic phase was
dried out, obtaining a partitioned subextract that amounted
to 1.03 g (43% recovery from the first raw extract, 10% from
the plant material). A control TLC showed that in the former
partition no oleuropein passed in the hydrocarbon phase,
while in the latter only a tiny amount of it was lost in thewater
phase.
2.4. Chromatographic Separation. Liquid chromatography
was performed by means of an MPLC system, consisting of
an Alltech 426 HPLC pump equipped with a VWR LaPrep
3101 detector. Glass columns from Omnifit were used, home-
packed with Fluka silica gel 100 RP-18 (15–35 𝜇m) stationary
phase. TLC was performed with Merck F
254
glass plates (RP-
18); the spots were detected using a UV lamp (254 and
366 nm) and additionally by spraying with sulfovanillin and
heating at 100∘C, obtaining an oleuropein coral pink spot on
TLC.
The above subextract was loaded on a RP-18 preparative
column and eluted with 80% water and 20% methanol. Frac-
tioningwasmonitored through theUVdetector (𝜆= 250 nm)
and with TLC. Finally, an oleuropein-enriched fraction was
collected and subjected to further study.
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2.5. LC/MS Analysis
2.5.1. Apparatus. LC/MS analysis was performed on the
above raw extract and subfractions by Nexera Liquid Chro-
matography Shimadzu (Kyoto, Japan) system equipped with
a DGU-20A3R Degasser, two LC-30AD Pumps, a SIL-30AC
Autosampler, a CTO-20AC column compartment, and a
CMB-20A Lite system controller. The system was interfaced
with a 3200 QTrap LC-MS/MS system (AB Sciex, Concord,
Canada) by a Turbo V interface equipped with an ESI probe.
The 3200QTrap data were processed byAnalyst 1.5.2 software
(Toronto, Canada).
2.5.2. UHPLC-MS/MS Conditions. The stationary phase was
a Kinetex C18 column (2.1mm × 100mm, 2.6 𝜇m) (Phe-
nomenex, Italy). The mobile phase was a mixture of ammo-
nium acetate 10.0mM in ultrapure water with the addition
of 0.1% acetic acid (A), and aqueous ammonium acetate
10.0mM/methanol 5/95 (v/v) with the addition of 0.1% acetic
acid (B), eluting at flow-rate 0.400mLmin−1 in the following
gradient conditions: 0.0–0.5min 5% B, 0.6–8.0min 65% B,
8.1–12.0min 100% B, and 12.1–15.0min 5% B. The injection
volume was 5.0 𝜇L. Oven temperature was set at 40∘C.
The turbo ion spray (TIS) ionization was obtained using
the Turbo V interface working in negative ion mode. The
instrumental parameters were set as follows: curtain gas (N
2
)
at 30 psig, nebulizer gas GS1 and GS2 at 50 and 40 psig,
respectively, desolvation temperature (TEM) at 550∘C, col-
lision activated dissociation gas (CAD) at 6 units of the
arbitrary scale of the instrument, and ion spray voltage (IS)
at −4500V.
The 3200 QTrap was used in scheduled multiple reaction
monitoring (sMRM) considering the transitions of each
species at a prefixed retention time. Unit mass resolution
was established and maintained in each mass-resolving
quadrupole by keeping a full width at half maximum
(FWHM) of about 0.7 u.
The analytes were previously subjected toMS/MS charac-
terization study, to identify the fragmentation patterns taking
place under increasing collisional energy. Characterization
experiments were carried out for direct infusion of 1.0mg L−1
standard solutions of each analyte connected through a T
valve to the syringe pump (syringe flow-rate 20.0𝜇Lmin−1;
chromatographic pump flow-rate 200 𝜇Lmin−1). For each
species, the most intense transition was used for the quan-
titative analysis and referred to as “quantifier” transition,
while the second intense one (the “qualifier” transition) was
employed in the identification step, as a confirmation. The
“quantifier” and “qualifier” transitions and the instrumental
potential values for each compound are reported in Table 1.
Calibration plots of five concentration levels (between
LOQ value and 1000.0 𝜇g L−1), relating the peak area of the
“quantifier” transition signal (𝑦) versus standard concentra-
tion (𝑥), were built for all the analytes. To avoid a possible
influence of the experimental error on the execution order of
analyses, the standard solutions were injected in randomized
order. For all the analytes a linear regression fit was used with
a weighting factor 1/𝑥 and for all the calibration plots a good
linearity with regression coefficients (𝑅2) always greater than
0.9982 was obtained.
Detection limit values expressed as the concentration of
the analyte that gives a signal equal to the average background
(𝑆blank) plus 3 times the standard deviation of the blank
(LOD = 𝑆blank + 3𝑠blank) are 0.3 𝜇g L
−1 for hydroxytyrosol
and 0.4 𝜇g L−1 for oleuropein.The quantitation limits (LOQ),
evaluated as LOQ= 𝑆blank + 10𝑠blank, are 1.0 𝜇g L
−1 for hydrox-
ytyrosol and 1.2 𝜇g L−1 for oleuropein.
2.6. In Vitro Cell Culture. In vitro experiments were carried
out using the tumorigenic malignant mesothelioma REN cell
line [1]. Cells were grown in DMEM, supplemented with 10%
foetal bovine serum (FBS, Euroclone), at 37∘C, in a 5% CO
2
,
fully humidified atmosphere.
2.7. Cell Viability Assay. Cell viability was determined on
REN cells by the MTT assay. Cells were settled in 96-well
plates for 24 h, exposed to various agents for 48 h as specified,
incubated with 100𝜇L/mL tetrazolium salt (MTT, 5mg/mL
in PBS) in cell culture mediumwithout serum for 3 h at 37∘C,
and treated with a solution of 1 N HCl-isopropanol (1 : 24,
v/v) followed by mixing to dissolve the dark-blue formazan
crystals formed. After a few minutes at room temperature,
the plates were read at 550 nm in a VMax microplate reader
(Molecular Devices, Sunnyvale, CA).
2.8. Intracellular Ca2+ Measurements. Cytosolic free Ca2+
concentration was measured in fura-2-loaded REN cells
using a microspectrophotometry fluorescence-ratio setup
equipped with a perfusion system, as previously described
[18]. Cells were incubated in loading buffer containing 10 𝜇M
fura-2-AM at 37∘C for 30 minutes, washed with buffer, and
mounted on the stage of an inverted microscope (Axiovert
Zeiss, Germany), where they were continually superfused
with different solutions. Cells were illuminated by a xenon
lamp through a wavelength selector monochromator; emis-
sionwas observed through×40 quartz objective and recorded
by a photomultiplier.The ratio𝐸
340
/𝐸
380
was calculated every
40msec to acquire a time-dependent internal Ca2+ sensitive
signal.
At the end of each experiment, cells were incubated with
10 𝜇M ionomycin in a Ca-free solution containing 2mM
EGTA for 20−40min until the ratio reached a minimum
value (𝑅min); then EGTA was washed out, normal external
Ca2+ (1mM) was restored, and the ratio readily reached a
maximum value (𝑅max). Finally, MnCl2 (5mM) was added to
the bath to quench the fura-2 fluorescence and determine the
background (cell autofluorescence) values. The fluorescence
emissions relative to each excitation wavelength (𝐸
340
and
𝐸
380
, resp.) were corrected for this background signal before
ratio 𝑅 = 𝐸
340
/𝐸
380
determination. Internal Ca2+ was cal-
culated according to the Grynkiewicz equation [19].
2.9. Statistics. Statistics were obtained with the 𝑅 package,
version 3.0.1 (http://www.r-project.org/foundation/), using 𝑡-
test with Bonferroni’s correction for multiple comparisons.
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Table 1: sMRM NI transitions (Q1 and Q3 masses) and mass spectrometry parameters. The two most sensitive transitions for each species
were monitored.
Analytes Q1 (𝑚/𝑧) Q3 (𝑚/𝑧) 𝑡
𝑅
(min) DP (V) EP (V) CEP (V) CE (V) CXP (V)
Hydroxytyrosol 153 123/93 3.4 −34 −75 −17.32 −20/−31 −1.08/−1.35
Oleuropein 539 275/307 7.9 −40 −5 −31.61 −28/−29 −1.89/−2.12
𝑡𝑅: retention time; DP: Declustering Potential; EP: Entrance Potential; CEP: Collision cell Entrance Potential; CE: Collision Energy; CXP: Collision cell eXit
Potential.
Table 2: Percent content (w/w) of oleuropein and hydroxytyrosol in
different olive leaf extracts.
RE SE EF
Oleuropein 21.4 ± 0.3 43.2 ± 1.4 60.1 ± 0.3
Hydroxytyrosol 0.37 ± 0.04 0.91 ± 0.03 n.d.
Data are means ± s.d. of three independent measures. RE: raw extract; SE:
subextract; EF: oleuropein-enriched fraction; n.d.: not detected.
Cytotoxicity was determined using a logistic dose-response
curve as reported in Ranzato et al. [20]. Analysis of data from
Ca2+ measurements and determination of EC
50
values were
done by Sigmaplot 8 (Systat Software Inc., San Jose, CA).
3. Results
Multistep processing of olive leaves consisted of the following:
(1) extraction of dried, minced leaves in 2-propanol : water
(9 : 1), to obtain a raw extract; (2) partitioning between
methanol : water (3 : 1) and toluene : petroleum ether (2 : 1),
followed by partitioning of the dried aqueousmethanol phase
between water and 2-butanone, to obtain a subextract; (3)
liquid (column) chromatography separation of the dried
organic phase, to obtain an oleuropein-enriched fraction (see
Methods). Oleuropein and hydroxytyrosol quantification in
the raw extract and fractions was achieved by LC-MS tech-
nique. Data showed a progressive enrichment in oleuropein,
up to a value of 60% w/w in the final fraction obtained
through chromatographic separation (Table 2).
In order to evaluate the pharmacological potentials of the
oleuropein-enriched, leaf extract fraction, and of its major
component oleuropein, we tested the ability of mobilizing
cell Ca2+ in mesothelioma REN cells. Intracellular Ca2+ is a
main regulator of cell growth, and therefore agents able to
deregulate Ca2+ dynamics can be possibly used to hinder cell
proliferation.
Fura-2-loaded cells were transiently exposed by perfusion
to the oleuropein fraction. This treatment induced [Ca2+]i
rises followed by a prompt recovery of the baseline level upon
washout (Figure 1(a)). Data indicate that the observed [Ca2+]i
spikes are not due to cell membrane injury but rather depend
on the influx of Ca2+ through membrane Ca2+ channels.
Moreover, the [Ca2+]i transient elevations were dependent
on the nominal concentration of oleuropein (10–30 𝜇M)
contained in the extract (Figure 1(b)).
To explore more in depth the mechanism of action, we
also studied the Ca2+ mobilizing property of standard oleu-
ropein. Similar to the oleuropein fraction, increasing doses of
standard oleuropein, in the range 10–100 𝜇M, induced dose-
dependent [Ca2+]i spikes (Figures 1(c) and 1(d)). Removal
of Ca2+ from the external solution almost abolished the
oleuropein effect (Figure 1(d)). In addition, the use of the
T-type Ca2+ channel inhibitor NNC-55-0396 (Sigma, ≥98%,
HPLC) [21] reversibly reduced the Ca2+ spike induced by
the highest dose of 100 𝜇M oleuropein (Figures 1(c) and
1(d)), suggesting at least a partial involvement of T-type Ca2+
channels.
We tried to provide some hint as to which oleuropein
moiety could be active on cell Ca2+ mobilization. Hydrox-
ytyrosol is known to induce modulatory effects on [Ca2+]i
[22]. We therefore used standard hydroxytyrosol on fura-2-
loaded REN cells, observing the induction of dose-dependent
[Ca2+]i spikes that also in this case were inhibited by Ca
2+-
free medium. Moreover, NNC-55-0396 also hindered the
hydroxytyrosol-induced [Ca2+]i spikes, with 80% inhibition
at 10 𝜇M hydroxytyrosol and 65% inhibition at 100𝜇M
hydroxytyrosol (Figures 1(e) and 1(f)).
As for comparative quantification of the effect on [Ca2+]i,
dose-response data allowed estimating an EC
50
of 12 𝜇M
for hydroxytyrosol and of 53𝜇M for oleuropein, showing
that hydroxytyrosol is more powerful than oleuropein in
inducing Ca2+ spikes. No established drug is known to
induce T-type Ca2+ channel opening. We therefore used
the natural phenolic epigallocatechin-3-gallate (EGCG) as
positive control, since we had previously shown that this
compound induces Ca2+ rise in REN cells via T-type Ca2+
channels [23]. Presently, EGCG was found to induce dose-
dependent [Ca2+]i spikes with an estimated EC50 of 69 𝜇M
(Figures 1(e) and 1(f)).
The oleuropein-enriched fraction and standard oleu-
ropein were separately used on REN cells at nominally
equivalent oleuropein concentrations, in order to verify their
antiproliferative activity. EGCG was used as positive control
also in this case, since we had previously assessed its cytotox-
icity on REN cells [24]. The cytotoxic effect of the oleuropein
fraction (IC
50
= 22𝜇g/mL expressed as oleuropein) was
slightly, but not significantly, stronger than that of standard
oleuropein (IC
50
= 25 𝜇g/mL). Both substances were slightly
more cytotoxic than EGCG (IC
50
= 33 𝜇g/mL) (Figure 2).
4. Discussion
The oleuropein yield in our enriched fraction is very close to
the highest concentrations present in commercially available
olive leaf extract formulations [25], suggesting its possible
direct use in medicinal preparations. Despite a vast array of
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Figure 1: Time course of [Ca2+]i level in mesothelioma REN cells loaded with fura-2 and alternatively exposed to the oleuropein-enriched
fraction from olive leaf extract (a, b), to standard oleuropein (c, d) or to standard hydroxytyrosol (e, f). The oleuropein fraction and standard
oleuropein have been used at nominal concentrations of oleuropein, expressed in𝜇moles/L. (a) Induction of [Ca2+]i spikes in RENcells loaded
with fura-2 by transient exposure to the oleuropein fraction (ole) at 10 and 30 𝜇Moleuropein. (b) Quantification of dose-dependent induction
of [Ca2+]i spikes by the oleuropein fraction. Data are means ± s.e.m. (𝑛 ≥ 3) of Δ[Ca
2+
]i (difference between peak value and basal level of
[Ca2+]i). (c) Induction of [Ca
2+
]i spikes in REN cells by transient exposure to standard oleuropein (ole) at 10 and 100 𝜇M. The inhibitory
effect of the T-type Ca2+ channel blocker NNC-55-0396 (5 𝜇M) and recovery after washout are shown. (d) Quantification of dose-dependent
induction of [Ca2+]i spikes by standard oleuropein (EC50 = 53 𝜇M), and inhibition by Ca
2+-free medium (0 Ca) or NNC-55-0396 measured
at 100 𝜇M oleuropein. Data as above; ∗ = 𝑝 ≤ 0.01, 𝑡 test. (e) Induction of [Ca2+]i spikes by standard hydroxytyrosol (HT) at 10 and 100𝜇M,
inhibitory effect of NNC-55-0396, and recovery after washout. (f) Quantification of dose-dependent effect of hydroxytyrosol (EC
50
= 12 𝜇M)
and inhibition by Ca2+-free medium (0 Ca) or NNC-55-0396 measured at 10 and 100 𝜇M hydroxytyrosol. Data and statistics as above. (g, h)
Induction of [Ca2+]i spikes by EGCG and statistics of dose-dependent effect (EC50 = 69 𝜇M). Data as above.
data on possible oleuropein cellular targets, our data about
the effects on intracellular Ca2+ are new. The activity of
oleuropein was slightly lower than that of the oleuropein-
enriched fraction, possibly due to the occurrence in the
fraction of other secoiridoid esters known to be present in
olive leaves, such as demethyloleuropein, ligstroside, and
oleuroside [26], allegedly coeluting with oleuropein in the
HPLC separation.
We have previously found that low-voltage-activated T-
type Ca2+ channels, specifically the isoform Cav3.2, medi-
ate the Ca2+ rise induced in REN cells by the green tea
polyphenol epigallocatechin-3-gallate [23]. We have also
shown that Cav3.2 is responsible for Ca2+ spikes induced by
epigallocatechin-3-gallate in MCF-7 breast cancer cells [20].
In the present study, an involvement of T-type Ca2+ channels
is called into question also for the Ca2+ mobilizing effect of
oleuropein by the use of Ca2+-freemedium, indicating a Ca2+
entry process, and of the specific T-type Ca2+ channel blocker
NNC-55-0396.
The stronger activity of hydroxytyrosol with respect to
oleuropein and the inhibitory effect of NNC-55-0396 suggest
that the hydroxytyrosol moiety could be the active site
mediating the oleuropein effect on T-type Ca2+ channels.
The almost complete inhibition exerted by NNC-55-0396
on hydroxytyrosol at lower dose, compared with the partial
inhibition at higher dose, seems to indicate that the effect
of olive phenolics mostly involves a T-type Ca2+ channel-
dependent mechanism at low doses (≤10 𝜇M). At higher
doses, these phenolics could instead act through amore com-
plex mechanism, possibly including other Ca2+ mobilizing
systems.
T-type Ca2+ channels have been linked to various kinds
of epilepsy [27], while they are thought to play a role in
tumor cell cycle progression andproliferation [28, 29].Hence,
much interest has been raised in their possible therapeutic
targeting with more or less specific inhibitors [30, 31].
However, the blockage of these channels does not seem to be
an exclusive strategy in antitumor therapy. Antiproliferative
effects obtained with mibefradil and pimozide, two T-type
Ca2+ channel inhibitors, have been partially ascribed to
some unidentified mechanism [32]. Also, cell cycle progres-
sion needs a fine tuning of [Ca2+]i oscillations, suggesting
that intracellular Ca2+ dysregulation determining transient
[Ca2+]i rise may also interfere with tumor development, pos-
sibly leading to cell death [33]. Accordingly, pharmacological
agents like olive phenolics, able to abnormally activate T-
type Ca2+ channel activity, could be promising tools for the
inhibition of cancerous cell growth.
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Figure 2: Dose-response data of cell viability obtained with the MTT assay after exposure of REN cells for 48 h to the oleuropein-enriched
fraction (60% oleuropein) (a), standard oleuropein (b), and EGCG (c). The charts show means ± s.d. of percent MTT-formazan absorbance,
logistic regression lines, and IC
50
values expressed as 𝜇g/mL (95% CI). Concentrations are normalized as the logarithm of 𝜇g/mL.
In apparent contrast with the present data, it has been
previously shown that an olive leaf extract exerts antago-
nistic effects on high-voltage-activated L-type Ca2+ chan-
nel, thereby inducing blood pressure lowering [34, 35]. A
comparison between these previous reports and our study is
difficult tomake, owing to differences in both the extracts and
the experimental models. However, such a complex of data
advocates an intriguing scenario, entailing divergent effects of
major olive phenolics on low-voltage and high-voltage Ca2+
channels.
More insight into the possibility of using the oleuropein
fraction in antitumor treatment formesothelioma is provided
by our cytotoxicity tests, indicating that the antiproliferative
activity of the oleuropein fraction essentially depends on
its major constituent oleuropein. The United States National
Cancer Institute plant screening program has established that
a plant extract can be deemed to have a cytotoxic effect if
IC
50
for incubations of 48–72 h is 20𝜇g/mL or lower [36].
Our oleuropein-enriched fraction has an oleuropein content
of 60% and a cytotoxicity IC
50
of 22 (17–29)𝜇g/mL in terms
of oleuropein. We can then estimate IC
50
of 36.7 (28.3–
48.3) 𝜇g/mL for the oleuropein-enriched fraction as a whole.
Hence, our oleuropein fraction is close to the cytotoxicity
threshold established by NCI and could therefore be appro-
priate for the development of synergistic treatments allowing
reducing the doses of highly toxic conventional drugs, as
previously suggested for EGCG [1]. Such an approach could
overcome critical drawbacks in the treatment of chemoresis-
tant tumors like malignant mesothelioma [37].
There is no established standard dose of oleuropein
for humans, but in acute toxicity studies, oleuropein and
hydroxytyrosol have shown no lethality or adverse effects
in mice up to doses of 1000 and 2000mg/kg, respec-
tively. In addition, studies conducted on humans with
olive extract or its polyphenolics have shown no undesired
effects [38, 39]. Pharmacokinetics of oral oleuropein and
its metabolite hydroxytyrosol in human plasma indicates
peaks of about 0.004 𝜇g/mL (0.01𝜇M) for oleuropein, while
its main metabolite hydroxytyrosol can reach values of
about 0.15𝜇g/mL (1 𝜇M) [40]. These values are close to
the effective concentrations observed in our experiments
for hydroxytyrosol, but intravenous delivery of oleuropein
should allow reaching much higher blood peaks. Hence,
pharmacokinetics data indicate that plasma concentrations
compatible with dysregulating effects on tumor cell Ca2+
could be easily achieved upon clinical administrations of
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oleuropein, followed by its conversion into the more effective
metabolite hydroxytyrosol.
5. Conclusions
We have shown a method to obtain oleuropein-enriched
olive leaf extract fractions that could be of industrial interest,
because extraction is generally competitive with chemical
synthesis for complex molecules like oleuropein. In addi-
tion, we have highlighted a novel mechanism of action for
oleuropein and its metabolite hydroxytyrosol, consisting in
a dysregulation of Ca2+ dynamics occurring via T-type Ca2+
channels. This kind of effect suggests a possible use of the
oleuropein fraction from olive leaves in the treatment of
mesothelioma.
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